Crosshairs

Tech Titans in Legal Crosshairs: X Corp and X.AI Sue Apple and OpenAI Over Alleged Antitrust Violations

by

Dallas, Texas — A federal lawsuit filed on Monday by X Corp. and X.AI LLC is challenging what they describe as an anticompetitive partnership between Apple and OpenAI concerning the exclusive integration of ChatGPT. The plaintiffs allege that this collaboration infringes upon federal competition regulations and fortifies monopolistic practices in both companies’ markets. The lawsuit identifies Apple and OpenAI as maintaining substantial market shares — Apple commands about 65 percent of the U.S. smartphone market, while OpenAI holds nearly 80 percent in the generative AI chatbot sector. By leveraging their dominance, the plaintiffs argue that … Read more

Republican Lawmakers Target D.C.’s Traffic Laws: No Right-on-Red and Speed Cameras in the Crosshairs

by

Republican lawmakers are seeking to significantly diminish the District of Columbia’s authority to enforce traffic regulations, including a relatively recent ban on right turns at red lights and the operation of speed cameras. These provisions were embedded in an appropriations bill that Congress is required to pass by October, marking yet another attempt to influence traffic management in the nation’s capital. Despite representing districts far removed from Washington, D.C., these lawmakers wield constitutional power over the city’s policies. Congressman Jake Ellzey of Texas, a member of the House Appropriations Committee, expressed his discontent with the … Read more

Federal Court Keeps Boies Schiller in the Crosshairs of Pharmaceutical Legal Battle

by

Miami, Florida — A federal court has ruled that Boies Schiller Flexner LLP remains a party in an ongoing lawsuit involving pharmaceutical mass tort firms and their former legal counsel. The case highlights complex legal battles over alleged malpractice and breach of fiduciary duty within the pharmaceutical industry. The litigation revolves around claims made by several mass tort firms who allege that they were misled by their previous counsel regarding the management of various cases. This development underscores the contentious relationships that can arise among legal firms, especially in high-stakes environments like pharmaceutical litigation, where … Read more